Tenon Medical (NASDAQ:TNON – Get Free Report) is anticipated to announce its Q1 2025 earnings results before the market opens on Tuesday, May 13th. Analysts expect the company to announce earnings of ($1.06) per share and revenue of $0.76 million for the quarter.
Tenon Medical Stock Up 1.4%
NASDAQ TNON opened at $1.13 on Monday. Tenon Medical has a 52 week low of $0.91 and a 52 week high of $15.79. The stock has a market capitalization of $6.98 million, a PE ratio of -0.04 and a beta of 1.23. The firm has a 50 day moving average of $1.32 and a two-hundred day moving average of $1.83.
Analyst Ratings Changes
Separately, Alliance Global Partners started coverage on shares of Tenon Medical in a report on Wednesday, April 9th. They set a “buy” rating and a $3.00 price target for the company.
About Tenon Medical
Tenon Medical, Inc, a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints.
Featured Articles
- Five stocks we like better than Tenon Medical
- NYSE Stocks Give Investors a Variety of Quality Options
- Constellation Powers Up With Reinforced AI Data Center Strategy
- Growth Stocks: What They Are, What They Are Not
- Top Analyst-Rated Healthcare Stocks to Watch Now
- Golden Cross Stocks: Pattern, Examples and Charts
- GlobalFoundries Stock Hits Bottom: Is a Rebound Coming?
Receive News & Ratings for Tenon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenon Medical and related companies with MarketBeat.com's FREE daily email newsletter.
